For the past several months, I have been working with Mark Hillen, the editor of The Ophthalmologist, in providing him with background information about stem cells and gene therapy used in ophthalmology to treat various retinal diseases. Articles, based on my information, along with material developed by Mark, have been published in past issues of his magazine. (Stem Cell Clinical Trials and Gene Therapy Clinical Trials.)
The Ophthalmologist is a new professional journal, published by Texere Publishing, for a target audience of ophthalmologists and industry professionals, mainly based in Europe.
The latest issue (February 2014) contains an (Read more...)